Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways

Management is optimistic as the new Dombivli hospital ramps up, despite it causing a 9.5 crore EBITDA drag this quarter.

Jupiter Life Line Hospitals Other Announcement

Jupiter Life Line Hospitals Limited has authorized specific Key Managerial Personnel for determining and disclosing material events under SEBI Regulation 30(5).

Jupiter Life Line Hospitals Management Change

Jupiter Life Line Hospitals Limited has appointed Mr. Harshad Gaurishankar Purani as the new Chief Financial Officer, effective July 31, 2026.

Jupiter Life Line Hospitals Merger & Restructuring Worth ₹3.78 Cr

Jupiter Life Line Hospitals' subsidiary, Jupiter Hospital Pharmacy, acquired 100% of Sulcus Private Limited for ₹3.78 Crore. This move aims to expand pharmaceutical manufacturing capabilities.

Value

₹3.78 Cr

Jupiter Life Line Hospitals Investor Presentation: Key Takeaways

Jupiter Life Line Hospitals reported Q1FY27 revenue growth of 16.2% YoY, while PAT declined 14.7% due to higher depreciation and finance costs from the new Dombivli facility.

Jupiter Life Line Hospitals Q1 FY27 Results: Net Profit ₹37.5 Cr, Down 14.6% YoY

Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹411 Cr (+16.4% YoY) and net profit of ₹37.5 Cr (-14.6% YoY) for Q1 FY27.

Key figure

Net profit ₹37.5 Cr · -14.6% YoY

Jupiter Life Line Hospitals Share Pledge

Catalyst Trusteeship Ltd disclosed the creation of a pledge over 1,67,59,750 equity shares of Jupiter Life Line Hospitals Ltd.

Jupiter Life Line Hospitals Board Meeting Date

Jupiter Life Line Hospitals Limited has scheduled a board meeting on July 31, 2026, to consider and approve the company's unaudited financial results for the quarter.

Jupiter Life Line Hospitals Other Announcement

Jupiter Life Line Hospitals Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending June 30, 2026.

Jupiter Life Line Hospitals Capital Structure Change

Jupiter Life Line Hospitals fixed July 24, 2026, as the record date for its 1:5 stock split. Each Rs.10 share will be subdivided into five Rs.2 shares.

Jupiter Life Line Hospitals Annual General Meeting

Jupiter Life Line Hospitals concluded its 24th AGM today. Shareholders approved the FY26 financial statements, a stock split, and the appointment of Dr. Ajay Thakker as Chairman.

Jupiter Life Line Hospitals Annual Report

Jupiter Life Line Hospitals Ltd filed its FY 2025-26 Annual Report, noting an AGM on July 17, 2026. The report outlines strategic expansion and operational highlights.

Jupiter Life Line Hospitals Earnings Call: Key Takeaways

Jupiter reports strong FY26 performance with 15.2% revenue growth to ₹1,499.8cr. Focus remains on greenfield expansion in Western India with asset-heavy ownership model.

Jupiter Life Line Hospitals Other Announcement

Jupiter Life Line Hospitals submitted its FY26 Annual Secretarial Compliance Report. The auditor confirmed adherence to SEBI regulations, reflecting strong corporate governance and regulatory compliance.

Jupiter Life Line Hospitals Earnings Call: Key Takeaways

Jupiter is aggressively expanding in Western India, leveraging its asset-heavy model to build high-capacity flagship hospitals in Mumbai and Pune.

Jupiter Life Line Hospitals Management Change

Jupiter Life Line Hospitals CFO Mr. Sivasis Sen resigned effective May 31, 2026, due to personal commitments. The company is now identifying a suitable successor.

Jupiter Life Line Hospitals Board Meeting Date

Jupiter Life Line Hospitals scheduled a board meeting for May 15, 2026. Directors will consider financial results, interim dividends, and a potential stock split.

Jupiter Life Line Hospitals Share Pledge

Catalyst Trusteeship Limited, acting as Debenture Trustee, received a pledge of 33,51,950 equity shares (5.11% stake) of Jupiter Life Line Hospitals Limited. The shares were pledged in favour of the trustee for the benefit of debenture holders. The transaction was disclosed under SEBI SAST Regulation 29(1).

Value

₹65.57 Cr

Jupiter Life Line Hospitals Q3 FY26 Results: Net Profit ₹42.5 Cr, Down 18.6% YoY

Jupiter Life Line Hospitals Ltd reported net profit of ₹42.5 Cr (-18.6% YoY) for Q3 FY26.

Key figure

Net profit ₹42.5 Cr · -18.6% YoY

Jupiter Life Line Hospitals Other Announcement

Jupiter Life Line Hospitals Limited's promoter, Dr. Ankit Thakker, declared that the promoter group made no direct or indirect share encumbrances during FY 2025-26. The total promoter and promoter group shareholding stands at 40.91%.

Jupiter Life Line Hospitals Other Announcement

Dr. Ankit Thakker, on behalf of the promoters of Jupiter Life Line Hospitals Limited, declared that no shares were encumbered during the financial year ended March 31, 2026. This is a standard annual compliance disclosure under SEBI Takeover Regulations confirming the absence of any new pledges by the promoter group.

Jupiter Life Line Hospitals Other Announcement

Jupiter Life Line Hospitals submitted its quarterly certificate under SEBI Regulation 74(5) for the period ended March 31, 2026. The registrar, KFin Technologies, confirmed that the entire holding of the company is in dematerialized form and no rematerialization requests were received during the quarter.

Execution

Quarter ended March 31, 2026